Laylay, Elisabeth H.

HRN: 28-77-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2026
CEFTRIAXONE 1G (VIAL)
04/07/2026
04/14/2026
IV
1 Gram
Q12H
For OR Plating Tibia Right
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: